Mudryk returns to football immediately after the conclusion of the doping proceedings
Mykhailo Mudryk is once again eligible to train and play for Chelsea after the lengthy doping proceedings ended with an agreement between the player, the Football Association and the World Anti-Doping Agency. The FA announced that the parties resolved the appeal proceedings on 30 July 2026, with the Ukrainian international accepting a period of ineligibility equal to the time he had already spent away from football. His ineligibility to compete has therefore ended, and the 25-year-old winger can immediately return to his professional duties. The decision is particularly significant because an independent Regulatory Commission had imposed a four-year ban at the beginning of 2026, which would have seriously jeopardised the stage of his career during which footballers are usually at their sporting peak. However, the conclusion of the proceedings does not mean that the original finding was simply overturned: as part of the agreement, Mudryk accepted that he had committed anti-doping rule violations, but the final sanction was reduced to the period he had already served.
The central reason for this outcome was a change in WADA's technical criteria for laboratory reporting of very low concentrations of certain prohibited substances. According to the FA's official statement, had the same sample been collected under the new technical requirements, the concentration of meldonium found in Mudryk's sample would not have been reported as an adverse analytical finding and would not have resulted in an anti-doping rule violation. The new criteria are not retroactive, so they did not automatically erase the earlier decision. Nevertheless, together with other circumstances of the case, they enabled a negotiated settlement of the appeal before the Court of Arbitration for Sport. The FA emphasised that the proceedings were concluded in accordance with the World Anti-Doping Code and its own 2024 anti-doping regulations.
From the October 2024 sample to a four-year ban
The case began on 22 October 2024, when Mudryk underwent an out-of-competition doping control. The analysis revealed the presence of a low concentration of meldonium, a substance included on WADA's Prohibited List. The Football Association informed the player of the finding on 4 December 2024 and immediately imposed a provisional suspension. Chelsea confirmed several days later that the club was aware of the adverse finding, while Mudryk publicly maintained that he had never knowingly taken prohibited substances. At the time, the club announced that it would cooperate with the relevant authorities to determine how the substance had entered his body.
On 23 May 2025, the FA formally charged Mudryk with violations of two anti-doping provisions relating to the presence and use of a prohibited substance. A hearing before an independent Regulatory Commission was held from 7 to 9 January 2026. The Commission concluded that the violations had been proven and imposed a four-year period of ineligibility. Such a penalty represents one of the most severe standard sanctions in the anti-doping system, particularly when the substance detected is not classified among the less serious, specifically designated violations. Following the decision, Mudryk appealed to the Court of Arbitration for Sport in Lausanne, the international institution that resolves disputes between athletes, clubs, federations and anti-doping organisations.
The appeal proceedings did not end with a conventional arbitral award in which one party prevailed entirely. Instead, the FA, WADA and Mudryk reached an agreement after new laboratory standards had been adopted. Under that arrangement, the player accepted responsibility for the violations with which he had been charged, while the relevant authorities accepted that the time he had already spent suspended would constitute his final punishment. As he had been out of competition from the beginning of December 2024 until the end of July 2026, this amounted to approximately twenty months without an official appearance. In practical terms, the four-year ban no longer has any effect, and from 30 July 2026 Mudryk has been considered free to return to training and matches.
Why WADA's new criteria changed the outcome
In March 2026, WADA approved the TD2027MRL technical document, which introduces minimum reporting levels for certain substances without a conventionally defined threshold. The purpose of the document is to harmonise how accredited laboratories report very low concentrations and reduce the possibility that analytical traces lacking sufficient reliability or sporting significance automatically trigger proceedings. The document is formally scheduled to take effect on 1 January 2027, but in Mudryk's case the FA explicitly stated that, under the new technical approach, his meldonium concentration would have been below the reporting level. This became a decisive circumstance in the negotiations to conclude the appeal proceedings.
It is important to distinguish the list of prohibited substances from the laboratory rules governing when a finding must be reported. Meldonium has not been removed from WADA's List, and its use in sport may still constitute a doping violation. The change concerns the minimum concentration that a laboratory must report as an adverse finding, not the general permissibility of the substance. Such standards exist to ensure that laboratories in different countries act consistently and that results are comparable. In Mudryk's case, it was precisely the exceptionally low concentration that became crucial, because under the new standard it would not have reached the level required for official reporting.
The official decision also demonstrates how much the anti-doping system depends on developments in analytical science. Laboratories can now detect exceptionally small traces of substances, but the mere technical ability to detect them does not always answer whether a result has sufficiently reliable legal or sporting significance. Minimum reporting levels are intended to distinguish the mere presence of a microscopic trace from a finding that justifies formal proceedings. The FA therefore stressed that the new document has no retroactive effect, but accepted that the change in scientific standards had to be taken into account when resolving an active appeal. This approach made a compromise possible without claiming that the rules in force at the time had not been applied or that the original laboratory finding had not existed.
Meldonium remains a prohibited substance
Meldonium is a medicine developed to treat certain heart and circulatory conditions, and outside sport it is used in some Eastern European and post-Soviet countries. WADA monitored it during 2015 as part of its monitoring programme and added it to the Prohibited List on 1 January 2016 after identifying patterns of use among athletes. The Agency classifies it as a metabolic modulator, prohibited both in and out of competition. Anti-doping rules are based on the principle of strict liability, meaning that an athlete is responsible for a prohibited substance found in their sample regardless of whether intentional use has been proven. Intent, degree of fault and a possible source of contamination then influence the type and duration of the sanction.
This principle is precisely why Mudryk's insistence that he did not knowingly take meldonium could not, by itself, bring the proceedings to an end. Athletes are required to monitor medicines, dietary supplements and other products they introduce into their bodies, while anti-doping organisations regularly warn that even unintentional ingestion can have serious consequences. On the other hand, the system provides for the possibility of reducing or eliminating a penalty when it is proven that the athlete was not at fault, was not negligent or that exceptional circumstances existed. In this case, not all evidence from the proceedings or the independent Commission's detailed reasoning has been made public, so it is currently impossible to determine reliably how meldonium entered the sample. The final agreement also did not confirm Mudryk's earlier claim of unintentional ingestion, but it acknowledged that the same analytical result would have remained below the reporting level under the new criteria.
This distinction is also important for public understanding of the decision. Mudryk was not cleared because meldonium became permitted or because it was proven that the finding was not genuine. The proceedings ended because new scientific and laboratory guidelines significantly changed the way the same concentration would be treated today, and the parties therefore accepted a proportionate sanction equal to the suspension already served. The legal wording preserves the fact that the player accepted anti-doping rule violations while simultaneously allowing him to return immediately. It is a compromise between the principle that the rules in force at the time must be respected and the need for the final outcome to reflect the current scientific standard.
Chelsea prepares a gradual reintegration
Chelsea welcomed the conclusion of the case and announced that it would assist Mudryk in returning to the squad and to a professional routine. The club pointed out that throughout the process the player had maintained that he had never knowingly or intentionally used a prohibited substance and that he did not know how traces of meldonium had entered his body. The club's statement also emphasised that Mudryk had acted professionally during the suspension and that the period away from football had been extremely difficult on both a personal and sporting level. Chelsea also reiterated that it respects the integrity of the anti-doping system and remains committed to its rules.
The right to return immediately does not mean that Mudryk is automatically ready for top-level competitive football. He played his last official match on 28 November 2024, when he scored in Chelsea's 2-0 victory over Heidenheim in the Conference League. Following his provisional suspension, he was not permitted to train with the first team at the club's Cobham training centre, so he maintained his fitness through individual programmes. Almost twenty months without official matches usually requires a gradual increase in workload, medical assessments and a return to tactical training before joining a full competitive schedule. The club must therefore assess his condition independently of the fact that the administrative ban has ended.
In a public message, Mudryk described the conclusion of the proceedings as the end of the most difficult period of his career. He thanked his family, the club, his legal team and the people who continued to support him, and reiterated that he had never knowingly or intentionally taken a prohibited substance. He identified returning to daily work and contributing on the pitch as his immediate objective. His statement reflects relief at the removal of the four-year restriction, but also an awareness that his sporting return will be a separate challenge.
Major sporting and financial significance for the player and the club
Chelsea signed Mudryk from Shakhtar Donetsk in January 2023 on a long-term contract, following one of the most high-profile transfers involving a young European winger during that period. According to club records, the Ukrainian international had made 73 appearances in all competitions before his suspension. His performances were marked by exceptional speed and an ability to attack space, but also by inconsistent finishing and difficulties adapting to the demands of the Premier League. The lengthy interruption came just as he had begun to show more consistent form in European matches, including his goal against Heidenheim in his final appearance before the suspension.
For Chelsea, the conclusion of the proceedings removes major legal and squad-planning uncertainty. A four-year ban would effectively have prevented the club from using the player for most of the remainder of his contract and would have seriously reduced his market value. The club can now include him in its sporting plans again and decide whether to retain him in the first team or enable him to return to regular football through another form of arrangement. As of 1 August 2026, Chelsea had not officially announced a final decision on Mudryk's role in the forthcoming season, so speculation about a guaranteed place in the starting line-up or a possible departure would be premature. It has only been confirmed that the club intends to support his reintegration and return to full physical fitness.
The decision also has broader significance for the Ukrainian national team. Before his suspension, Mudryk was one of the national side's most recognisable attacking players, capable of operating on the left wing and in transition. His availability once again opens the possibility of an international call-up, but the coaching staff will have to consider his lengthy absence and lack of competitive rhythm. The mere conclusion of the sanction does not guarantee a return to the national team, just as it does not guarantee playing time at Chelsea. That will be determined by his form, health and the sporting needs of the club and the national team.
A precedent with limited scope
Mudryk's case may attract the attention of other athletes and legal experts because of the way new laboratory criteria influenced active appeal proceedings. However, the decision does not mean that all earlier positive findings involving low concentrations will automatically be reviewed. The FA explicitly stated that the change to the technical document is not retroactive, and the agreement was reached after taking other circumstances of the specific case into account. Any potential claim by another athlete would depend on the rules of the relevant federation, the stage of the proceedings, the concentration of the substance, the evidence and the possibility of reaching an agreement under the World Anti-Doping Code.
Nevertheless, the case demonstrates that anti-doping law is not a static system. Lists of substances, laboratory methods and reporting criteria change as science develops, and sporting institutions must balance the protection of clean sport with an athlete's right to a proportionate and reliable process. In Mudryk's case, the original finding and responsibility did not formally disappear, but the assessment of their seriousness changed following the adoption of a more precise technical standard. The final result is therefore neither a complete exoneration nor confirmation of the full four-year penalty, but a negotiated conclusion of the case recognising the suspension already served.
For the Ukrainian footballer, the legal phase now ends and the sporting phase begins. He is permitted to train and compete immediately, but after almost two years away from official matches, his actual return will depend on physical preparation, the coaching staff's confidence and his ability to regain the level required for Chelsea and international football. The FA's decision has removed the greatest obstacle to his career, but only the coming months will reveal how quickly he can make up for lost time.
Sources:
- The Football Association – official chronology of the proceedings, the agreement with WADA and confirmation of the immediate return to competition (link)
- World Anti-Doping Agency – TD2027MRL technical document on minimum laboratory reporting levels (link)
- World Anti-Doping Agency – current List of Prohibited Substances and Methods and the legal status of meldonium (link)
- Chelsea FC – the club's initial statement on the adverse finding and Mudryk's position that he had not knowingly used prohibited substances (link)
- Sky Sports – statements from the player and the club, information about his last appearance and the context of his return to the squad (link)